Skip to content
DraconiticResearch
Search Sources API
186,546 studies31 sourcesUpdated 20 min ago
PreprintAll rights reservedmedRxiv

A Drug-Specific, Half-Life-Adjusted Framework for Classifying CNS-Active Systemic Therapy Exposure During and After Radiotherapy

  1. 1UT Southwestern Medical Center

Related

  1. Sex-specific associations between weight-adjusted waist index and peak expiratory flow in middle-aged and older Chinese adults: a cross-sectional study from CHARLS
    Li An, Zhiqing Fu, Hong Zhang +5
    BMC Public HealthPeer-reviewedCC BY-NC-ND 4.0Epidemiology & public healthCrossref
  2. Nanoparticle-Enabled Immune-Dose Shaping in Breast Cancer Radiotherapy: Reconciling Tumor Immunogenicity with Systemic Immune Preservation
    Sorinel Lunca, Stefan Morarasu, Gabriel Mihail Dimofte
    International journal of molecular sciencesPeer-reviewedCC BYFull textGeneral medicineEurope PMCCrossref
  3. Multi-Cycle Dosimetry of the Albumin-Binding Prostate-Specific Membrane Antigen Ligand [¹⁷⁷Lu]Ludotadipep in Metastatic Androgen Pathway Modulator-Resistant Prostate Cancer with Adjusted Red Marrow Modeling.
    Seunggyun Ha, Joo Hyun O, Chansoo Park +6
    PharmaceuticsPeer-reviewedCC BYFull textMedical imaging & radiologyEurope PMC
  4. An Integrated Framework for Classifying Intervention Mechanisms and Measurement Methodologies of Lower-Limb Proprioception in Patients with Stroke: A Systematic Review and Exploratory Meta-Analysis
    Ming-Yu Tian, Min-Young Lee, Min-Ki Jeon +1
    Journal of clinical medicinePeer-reviewedCC BYFull textGeneral medicineEurope PMCCrossref
  5. The Predictive Value of the Systemic Immune‐Inflammation Index Combined With Clinical Stage for the Prognosis of Oesophageal Cancer Patients Treated With Radiotherapy: A Retrospective Cohort Study and Meta‐Analysis
    Yao Ou, Qian Liu, Dan Yang +2
    Cancer medicinePeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCDOAJ
BibTeX
@misc{mitre2026drugspecific,
  title = {{A Drug-Specific, Half-Life-Adjusted Framework for Classifying CNS-Active Systemic Therapy Exposure During and After Radiotherapy}},
  author = {L. Pari Mitre and B. Drapkin and M. Dohopolski},
  howpublished = {medRxiv},
  year = {2026},
  month = jun,
  doi = {10.64898/2026.06.11.26354463},
  url = {https://www.medrxiv.org/content/10.64898/2026.06.11.26354463v3},
}
RIS
TY  - UNPB
TI  - A Drug-Specific, Half-Life-Adjusted Framework for Classifying CNS-Active Systemic Therapy Exposure During and After Radiotherapy
AU  - L. Pari Mitre
AU  - B. Drapkin
AU  - M. Dohopolski
PY  - 2026
DA  - 2026/06/11
PB  - medRxiv
DO  - 10.64898/2026.06.11.26354463
UR  - https://www.medrxiv.org/content/10.64898/2026.06.11.26354463v3
ER  -